Roche (RHHBY) Expected to Announce Earnings on Thursday

Roche (OTCMKTS:RHHBY) is anticipated to issue its resultson Thursday, July 23rd. Analysts expect the company to post earnings of $1.58 per share and revenue of $38.1416 billion for the quarter.

Roche Trading Up 0.3%

OTCMKTS:RHHBY opened at $51.14 on Wednesday. Roche has a 52-week low of $37.51 and a 52-week high of $60.85. The stock’s 50-day simple moving average is $51.34 and its 200 day simple moving average is $52.68. The company has a quick ratio of 1.12, a current ratio of 1.38 and a debt-to-equity ratio of 0.72.

Analyst Ratings Changes

Several research analysts have weighed in on the stock. HSBC cut shares of Roche from a “buy” rating to a “hold” rating in a report on Monday, July 6th. Argus raised shares of Roche from a “hold” rating to a “buy” rating in a research note on Monday, April 6th. Zacks Research cut Roche from a “hold” rating to a “strong sell” rating in a research report on Tuesday, July 14th. Finally, Morgan Stanley upgraded shares of Roche from an “underweight” rating to an “equal weight” rating and set a $46.00 price target for the company in a report on Friday, April 24th. Four research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $51.50.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in RHHBY. Verity Asset Management Inc. lifted its holdings in shares of Roche by 20.9% in the 3rd quarter. Verity Asset Management Inc. now owns 10,990 shares of the company’s stock worth $459,000 after purchasing an additional 1,898 shares in the last quarter. Hancock Whitney Corp increased its stake in Roche by 4.8% during the 3rd quarter. Hancock Whitney Corp now owns 24,488 shares of the company’s stock valued at $1,024,000 after purchasing an additional 1,116 shares in the last quarter. Atlas Capital Advisors Inc. bought a new stake in Roche during the 4th quarter valued at $192,000. Finally, IHT Wealth Management LLC bought a new position in shares of Roche in the fourth quarter valued at $400,000.

Roche Company Profile

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.